SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in agilon health, inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, April 23, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. ("agilon" or "the Company") (NYSE: AGL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between January 9, 2023 and January 4, 2024, inclusive (the "Class Period"), or purchased or otherwise acquired agilon common stock pursuant, or traceable to materials issued in connection with the Company's secondary public offering (the "SPO Materials") that occurred on or about May 16, 2023.are encouraged to contact the firm before May 20, 2024.       

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. The Company's purported visibility into medical costs and utilization costs was touted by agilon's management team. The Company failed to disclose the increased medical costs it had incurred due to higher utilization by Healthcare MA patients. The Company falsely stated its accounting reserves for higher utilization were adequate for its needs. The Company issued overly optimistic guidance for financial performance. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about agilon, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

SOURCE The Schall Law Firm